A common humoral background of intraocular and arterial blood pressure dysregulation

References

• Bonomi L, Marchini G, Marraffa M, et al. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology 2000;107:1287-93
   PubMed Web of Science ®Google Scholar
• Dielemans I, Vingerling JR, Algra D, et al. Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology 1995;102:54-60
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Knudtson MD. Intraocular pressure and systemic blood pressure: longitudinal perspective: the Beaver Dam Eye Study. Br J Ophthalmol 2005;89:284-7
   PubMed Web of Science ®Google Scholar
• Goel M, Picciani RG, Lee RK, et al. Aqueous humor dynamics: a review. Open Ophthalmol J 2010;4:52-9
   PubMedGoogle Scholar
• Leske MC, Connell AM, Wu SY, et al. Risk factors for open-angle glaucoma. The Barbados Eye Study. Arch Ophthalmol 1995;113:918-24
   PubMed Web of Science ®Google Scholar
• Macri FJ, Cevario SJ. The formation and inhibition of aqueous humor production. A proposed mechanism of action. Arch Ophthalmol 1978;96:1664-7
   PubMedGoogle Scholar
• Kiel JW, Hollingsworth M, Rao R, et al. Ciliary blood flow and aqueous humor production. Prog Retin Eye Res 2011;30:1-17
   PubMed Web of Science ®Google Scholar
• Brubaker RF. Flow of aqueous humor in humans [The Friedenwald Lecture]. Invest Ophthalmol Vis Sci 1991;32:3145-66
   PubMed Web of Science ®Google Scholar
• Caprioli J, Coleman AL. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study. Ophthalmology 2008;115:1123-1129 e3
   PubMed Web of Science ®Google Scholar
• Singh K, Shrivastava A. Intraocular pressure fluctuations: how much do they matter? Curr Opin Ophthalmol 2009;20:84-7
   PubMed Web of Science ®Google Scholar
• Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 2006;7:335-46
   PubMed Web of Science ®Google Scholar
• Guyton AC, Coleman TG, Cowley AV Jr, et al. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 1972;52:584-94
   PubMed Web of Science ®Google Scholar
• Beevers G, Lip GY, O’Brien E. ABC of hypertension: The pathophysiology of hypertension. BMJ 2001;322:912-16
   PubMed Web of Science ®Google Scholar
• Skrzypecki J, Ufnal M. Drug resistant hypertension - no simple way out. Kidney Blood Press Res 2015;40:66-76
   PubMed Web of Science ®Google Scholar
• Funk R, Rohen JW, Skolasinska K. Intraocular pressure and systemic blood pressure after administration of vasoactive substances in hypertensive and normal rats. Graefes Arch Clin Exp Ophthalmol 1985;223:145-9
   PubMed Web of Science ®Google Scholar
• Carel RS, Korczyn AD, Rock M, et al. Association between ocular pressure and certain health parameters. Ophthalmology 1984;91:311-4
   PubMed Web of Science ®Google Scholar
• Palm DE, Shue SG, Keil LC, et al. Effects of angiotensin, vasopressin and atrial natriuretic peptide on intraocular pressure in anesthetized rats. Neuropeptides 1995;29:193-203
   PubMed Web of Science ®Google Scholar
• Benigni A, Cassis P, Remuzzi G. Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med 2010;2:247-57
   PubMed Web of Science ®Google Scholar
• Taubman MB. Angiotensin II: a vasoactive hormone with ever-increasing biological roles. Circ Res 2003;92:9-11
   PubMed Web of Science ®Google Scholar
• Inoue T, Yokoyoma T, Koike H. The effect of angiotensin II on uveoscleral outflow in rabbits. Curr Eye Res 2001;23:139-43
   PubMed Web of Science ®Google Scholar
• Shah GB, Sharma S, Mehta AA, et al. Oculohypotensive effect of angiotensin-converting enzyme inhibitors in acute and chronic models of glaucoma. J Cardiovasc Pharmacol 2000;36:169-75
   PubMed Web of Science ®Google Scholar
• Costagliola C, Verolino M, De Rosa ML, et al. Effect of oral losartan potassium administration on intraocular pressure in normotensive and glaucomatous human subjects. Exp Eye Res 2000;71:167-71
   PubMed Web of Science ®Google Scholar
• Wang RF, Podos SM, Serle JB, et al. Effect of SPP 635, a renin inhibitor, on intraocular pressure in glaucomatous monkey eyes. Exp Eye Res 2012;94:146-9
   PubMed Web of Science ®Google Scholar
• Costagliola C, Di Benedetto R, De Caprio L, et al. Effect of oral captopril (SQ 14225) on intraocular pressure in man. Eur J Ophthalmol 1995;5:19-25
   PubMedGoogle Scholar
• Hirooka K, Baba T, Fujimura T, et al. Prevention of visual field defect progression with angiotensin-converting enzyme inhibitor in eyes with normal-tension glaucoma. Am J Ophthalmol 2006;142:523-5
   PubMed Web of Science ®Google Scholar
• Pelletier JS, Dicken B, Bigam D, et al. Cardiac effects of vasopressin. J Cardiovasc Pharmacol 2014;64:100-7
   PubMed Web of Science ®Google Scholar
• Holmes CL, Landry DW, Granton JT. Science review: Vasopressin and the cardiovascular system part 2 - clinical physiology. Crit Care 2004;8:15-23
   PubMed Web of Science ®Google Scholar
• Morton JJ, Padfield PL. Vasopressin and hypertension in man. J Cardiovasc Pharmacol 1986;8(Suppl7):S101-S6
   Web of Science ®Google Scholar
• Gondim EL, Liu JH, Costa VP, et al. Exogenous vasopressin influences intraocular pressure via the V(1) receptors. Curr Eye Res 2001;22:295-303
   PubMed Web of Science ®Google Scholar
• Bogner B, Runge C, Strohmaier C, et al. The effect of vasopressin on ciliary blood flow and aqueous flow. Invest Ophthalmol Vis Sci 2014;55:396-403
   PubMed Web of Science ®Google Scholar
• Balaban CD, Palm DE, Shikher V, et al. Mechanisms for vasopressin effects on intraocular pressure in anesthetized rats. Exp Eye Res 1997;65:517-31
   PubMed Web of Science ®Google Scholar
• Wallace I, Moolchandani J, Krupin T, et al. Effects of systemic desmopressin on aqueous humor dynamics in rabbits. Invest Ophthalmol Vis Sci 1988;29:406-10
   PubMed Web of Science ®Google Scholar
• Lacheretz F, Barbier A, Serradeil-Le Gal C, et al. Effect of SR121463, a selective non-peptide vasopressin V2 receptor antagonist, in a rabbit model of ocular hypertension. J Ocul Pharmacol Ther 2000;16:203-16
   PubMed Web of Science ®Google Scholar
• Suzuki T, Yamazaki T, Yazaki Y. The role of the natriuretic peptides in the cardiovascular system. Cardiovasc Res 2001;51:489-94
   PubMed Web of Science ®Google Scholar
• Potter LR, Yoder AR, Flora DR, et al. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol 2009;191:341-66.
   PubMedGoogle Scholar
• Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what’s next? Circulation 2002;105:2328-31
   PubMed Web of Science ®Google Scholar
• Lumsden NG, Khambata RS, Hobbs AJ. C-type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target. Curr Pharm Des 2010;16:4080-8
   PubMed Web of Science ®Google Scholar
• Yamaji T, Ishibashi M, Sekihara H, et al. Plasma levels of atrial natriuretic peptide in primary aldosteronism and essential hypertension. J Clin Endocrinol Metab 1986;63:815-18
   PubMed Web of Science ®Google Scholar
• Mittag TW, Tormay A, Ortega M, et al. Atrial natriuretic peptide (ANP), guanylate cyclase, and intraocular pressure in the rabbit eye. Curr Eye Res 1987;6:1189-96
   PubMed Web of Science ®Google Scholar
• Wolfensberger TJ, Singer DR, Freegard T, et al. Evidence for a new role of natriuretic peptides: control of intraocular pressure. Br J Ophthalmol 1994;78:446-8
   PubMed Web of Science ®Google Scholar
• Korenfeld MS, Becker B. Atrial natriuretic peptides. Effects on intraocular pressure, cGMP, and aqueous flow. Invest Ophthalmol Vis Sci 1989;30:2385-92
   PubMed Web of Science ®Google Scholar
• Sugrue MF, Viader MP. Synthetic atrial natriuretic factor lowers rabbit intraocular pressure. Eur J Pharmacol 1986;130:349-50
   PubMed Web of Science ®Google Scholar
• Sasaki T, Ushiyama M, Yamabayashi S, et al. [The effect of alpha-human atrial natriuretic polypeptides (alpha-hANP) on intraocular pressure in albino rabbits. First report: In albino rabbits with normal intraocular pressure]. Nippon Ganka Gakkai Zasshi 1986;90:1232-4
   PubMedGoogle Scholar
• Diestelhorst M, Krieglstein GK. The intraocular pressure response of human atrial natriuretic factor in glaucoma. Int Ophthalmol 1989;13:99-101
   PubMed Web of Science ®Google Scholar
• Tsukahara S, Sasaki T, Yamabayashi S, et al. Effect of alpha-human atrial natriuretic peptides on intraocular pressure in normal albino rabbits. Ophthalmologica 1988;197:104-9
   PubMed Web of Science ®Google Scholar
• Takashima Y, Taniguchi T, Yoshida M, et al. Ocular hypotensive mechanism of intravitreally injected brain natriuretic peptide in rabbit. Invest Ophthalmol Vis Sci 1996;37:2671-7
   PubMed Web of Science ®Google Scholar
• Takashima Y, Taniguchi T, Yoshida M, et al. Ocular hypotension induced by intravitreally injected C-type natriuretic peptide. Exp Eye Res 1998;66:89-96
   PubMed Web of Science ®Google Scholar
• Fernandez-Durango R, Moya FJ, Ripodas A, et al. Type B and type C natriuretic peptide receptors modulate intraocular pressure in the rabbit eye. Eur J Pharmacol 1999;364:107-13
   PubMed Web of Science ®Google Scholar
• Bianchi C, Anand-Srivastava MB, De Lean A, et al. Localization and characterization of specific receptors for atrial natriuretic factor in the ciliary processes of the eye. Curr Eye Res 1986;5:283-93
   PubMed Web of Science ®Google Scholar
• Eisenhofer G, Kopin IJ, Goldstein DS. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 2004;56:331-49
   PubMed Web of Science ®Google Scholar
• Prichard BN, Owens CW, Smith CC, et al. Heart and catecholamines. Acta Cardiol 1991;46:309-22
   PubMed Web of Science ®Google Scholar
• Franco-Morselli R, Elghozi JL, Joly E, et al. Increased plasma adrenaline concentrations in benign essential hypertension. Br Med J 1977;2:1251-4
   PubMed Web of Science ®Google Scholar
• Viquerat CE, Daly P, Swedberg K, et al. Endogenous catecholamine levels in chronic heart failure. Relation to the severity of hemodynamic abnormalities. Am J Med 1985;78:455-60
   PubMed Web of Science ®Google Scholar
• Floras JS, Aylward PE, Victor RG, et al. Epinephrine facilitates neurogenic vasoconstriction in humans. J Clin Invest 1988;81:1265-74
   PubMed Web of Science ®Google Scholar
• Tsirlin A, Oo Y, Sharma R, et al. Pheochromocytoma: a review. Maturitas 2014;77:229-38
   PubMed Web of Science ®Google Scholar
• Funk RH, Wagner W, Rohen JW. The effect of epinephrine on ciliary process vasculature and IOP studied by intraocular microendoscopy in the albino rabbit. Curr Eye Res 1992;11:161-73
   PubMed Web of Science ®Google Scholar
• Krieglstein GK, Langham ME. [The effect of repeated adrenaline application on intraocular pressure and pupil in the rabbit (author’s transl)]. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1975;196:267-77
   PubMedGoogle Scholar
• Lee PF. The influence of epinephrine and phenylephrine on intraocular pressure. AMA Arch Ophthalmol 1958;60:863-7
   PubMed Web of Science ®Google Scholar
• Langham ME, Krieglstein GK. The biphasic intraocular pressure response of rabbits to epinephrine. Invest Ophthalmol 1976;15:119-27
   PubMedGoogle Scholar
• Kronfeld PC. Early effects of single and repeated doses of L-epinephrine in man. Am J Ophthalmol 1971;72:1058-72
   PubMed Web of Science ®Google Scholar
• Urner-Bloch U, Aeschlimann JE, Gloor BP. Treatment of chronic simple glaucoma with an adrenaline/guanethidine combination at three different dosages (comparative double-blind study). Albrecht Von Graefes Arch Klin Exp Ophthalmol 1980;213:175-85
   PubMedGoogle Scholar
• Chiou GC. Effects of alpha 1 and alpha 2 activation of adrenergic receptors on aqueous humor dynamics. Life Sci 1983;32:1699-704
   PubMed Web of Science ®Google Scholar
• McAuliffe-Curtin D, Buckley C. Review of alpha adrenoceptor function in the eye. Eye (Lond) 1989;3:472-6
   PubMed Web of Science ®Google Scholar
• Ariens EJ, Simonis AM. Physiological and pharmacological aspects of adrenergic receptor classification. Biochem Pharmacol 1983;32:1539-45
   PubMed Web of Science ®Google Scholar
• Esler M, Kaye D. Measurement of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics. Heart Fail Rev 2000;5:17-25
   PubMedGoogle Scholar
• Goldstein DS, Lake CR. Plasma norepinephrine and epinephrine levels in essential hypertension. Fed Proc 1984;43:57-61
   PubMedGoogle Scholar
• Gherezghiher T, Hey JA, Koss MC. Systemic blood pressure and intraocular pressure relationship. J Ocul Pharmacol 1988;4:291-301
   PubMedGoogle Scholar
• Langham ME, Palewicz K. The pupillary, the intraocular pressure and the vasomotor responses to noradrenaline in rabbits. J Physiol 1977;267:339-55
   PubMed Web of Science ®Google Scholar
• Waitzman MB, Woods WD, Cheek WV. Effects of prostaglandins and norepinephrine on ocular pressure and pupil size in rabbits following bilateral cervical ganglionectomy. Invest Ophthalmol Vis Sci 1979;18:52-60
   PubMed Web of Science ®Google Scholar
• Pollack IP, Rossi H. Norepinephrine in treatment of ocular hypertension and glaucoma. Arch Ophthalmol 1975;93:173-7
   PubMedGoogle Scholar
• Langham ME, Diggs EM. Quantitative studies of the ocular response to norepinephrine. Exp Eye Res 1972;13:161-71
   PubMed Web of Science ®Google Scholar
• Eakins KE, Ryan SJ. The action of sympathomimetic amines on the outflow of aqueous humour from the eye. Br J Pharmacol Chemother 1964;23:374-82
   PubMed Web of Science ®Google Scholar
• Eakins KE. The effect of intravitreous injections of norepinephrine, epinephrine and isoproterenol on the intraocular pressure and aqueous humor dynamics of rabbit eyes. J Pharmacol Exp Ther 1963;140:79-84
   Web of Science ®Google Scholar
• Davenport AP, Hyndman KA, Dhaun N, et al. Endothelin. Pharmacol Rev 2016;68:357-418
   PubMed Web of Science ®Google Scholar
• Remuzzi G, Perico N, Benigni A. New therapeutics that antagonize endothelin: promises and frustrations. Nat Rev Drug Discov 2002;1:986-1001
   PubMed Web of Science ®Google Scholar
• Jankowska-Lech I, Terelak-Borys B, Grabska-Liberek I, et al. Decreased endothelin-1 plasma levels in multiple sclerosis patients: a possible factor of vascular dysregulation? Med Sci Monit 2015;21:1066-71
   PubMed Web of Science ®Google Scholar
• Agapitov AV, Haynes WG. Role of endothelin in cardiovascular disease. J Renin Angiotensin Aldosterone Syst 2002;3:1-15
   PubMed Web of Science ®Google Scholar
• Cardillo C, Kilcoyne CM, Cannon RO, 3rd, et al. Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo. Hypertension 2000;35:1237-41
   PubMed Web of Science ®Google Scholar
• MacCumber MW, Jampel HD, Snyder SH. Ocular effects of the endothelins. Abundant peptides in the eye. Arch Ophthalmol 1991;109:705-9
   PubMedGoogle Scholar
• Granstam E, Wang L, Bill A. Effects of endothelins (ET-1, ET-2 and ET-3) in the rabbit eye; role of prostaglandins. Eur J Pharmacol 1991;194:217-23
   PubMed Web of Science ®Google Scholar
• Sugiyama K, Haque MS, Okada K, et al. Intraocular pressure response to intravitreal injection of endothelin-1 and the mediatory role of ETA receptor, ETB receptor, and cyclooxygenase products in rabbits. Curr Eye Res 1995;14:479-86
   PubMed Web of Science ®Google Scholar
• Shoshani YZ, Harris A, Shoja MM, et al. Endothelin and its suspected role in the pathogenesis and possible treatment of glaucoma. Curr Eye Res 2012;37:1-11
   PubMed Web of Science ®Google Scholar
• Sugiyama T, Moriya S, Oku H, et al. Association of endothelin-1 with normal tension glaucoma: clinical and fundamental studies. Surv Ophthalmol 1995;39(Suppl1):S49-S56
   Web of Science ®Google Scholar
• Choritz L, Machert M, Thieme H. Correlation of endothelin-1 concentration in aqueous humor with intraocular pressure in primary open angle and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci 2012;53:7336-42
   PubMed Web of Science ®Google Scholar
• Noske W, Hensen J, Wiederholt M. Endothelin-like immunoreactivity in aqueous humor of patients with primary open-angle glaucoma and cataract. Graefes Arch Clin Exp Ophthalmol 1997;235:551-2
   PubMed Web of Science ®Google Scholar
• Tezel G, Kass MA, Kolker AE, et al. Plasma and aqueous humor endothelin levels in primary open-angle glaucoma. J Glaucoma 1997;6:83-9
   PubMed Web of Science ®Google Scholar
• Beamish RE, Das PK, Karmazyn M, et al. Prostaglandins and heart disease. Can J Cardiol 1985;1:66-74
   PubMedGoogle Scholar
• Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 2011;31:986-1000
   PubMed Web of Science ®Google Scholar
• Smith MC, Dunn MJ. The role of prostaglandins in human hypertension. Am J Kidney Dis 1985;5:A32-9
   PubMed Web of Science ®Google Scholar
• Wilson TW, Kaushal RD, Dubois M. Prostaglandins, the kidney, and hypertension. West J Med 1990;153:168-72
   PubMedGoogle Scholar
• Kerstetter JR, Brubaker RF, Wilson SE, et al. Prostaglandin F2 alpha-1-isopropylester lowers intraocular pressure without decreasing aqueous humor flow. Am J Ophthalmol 1988;105:30-4
   PubMed Web of Science ®Google Scholar
• Stern FA, Bito LZ. Comparison of the hypotensive and other ocular effects of prostaglandins E2 and F2 alpha on cat and rhesus monkey eyes. Invest Ophthalmol Vis Sci 1982;22:588-98
   PubMed Web of Science ®Google Scholar
• Bito LZ, Draga A, Blanco J, et al. Long-term maintenance of reduced intraocular pressure by daily or twice daily topical application of prostaglandins to cat or rhesus monkey eyes. Invest Ophthalmol Vis Sci 1983;24:312-19
   PubMed Web of Science ®Google Scholar
• Linden C, Alm A. Prostaglandin analogues in the treatment of glaucoma. Drugs Aging 1999;14:387-98
   PubMed Web of Science ®Google Scholar
• Alm A, Stjernschantz J. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group. Ophthalmology 1995;102:1743-52
   PubMed Web of Science ®Google Scholar
• Podos SM, Becker B, Kass MA. Prostaglandin synthesis, inhibition, and intraocular pressure. Invest Ophthalmol 1973;12:426-33
   PubMedGoogle Scholar
• Chiang TS, Thomas RP. Ocular hypertension following intravenous infusion of prostaglandin E 1. Arch Ophthalmol 1972;88:418-20
   PubMedGoogle Scholar
• Wizemann A, Ebinger G, Krey H, et al. Biphasic action of prostacyclin on intraocular pressure. Ophthalmologica 1982;184:204-9
   PubMed Web of Science ®Google Scholar
• Waitzman MB, Jackson RT, Kuck JF Jr, et al. Influences of metabolic-effective agents on nucleotide systems in ocular tissues. Am J Physiol 1966;210:1249-56
   PubMed Web of Science ®Google Scholar
• Eakins KE. Prostaglandin and non-prostaglandin mediated breeakdown of the blood-aqueous barrier. Exp Eye Res 1977;25(Suppl):483-98
   PubMed Web of Science ®Google Scholar
• Beitch BR, Eakins KE. The effects of prostaglandins on the intraocular pressure of the rabbit. Br J Pharmacol 1969;37:158-67
   PubMed Web of Science ®Google Scholar
• Starr MS. Further studies on the effect of prostaglandin on intraocular pressure in the rabbit. Exp Eye Res 1971;11:170-7
   PubMed Web of Science ®Google Scholar
• Camras CB, Bito LZ, Eakins KE. Reduction of intraocular pressure by prostaglandins applied topically to the eyes of conscious rabbits. Invest Ophthalmol Vis Sci 1977;16:1125-34
   PubMed Web of Science ®Google Scholar
• van Alphen GW, Wilhelm P. Effect of prostaglandins on the blood-aqueous barrier of the perfused cat eye. Invest Ophthalmol Vis Sci 1978;17:60-3
   PubMed Web of Science ®Google Scholar
• Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42
   PubMed Web of Science ®Google Scholar
• Bauer JA, Booth BP, Fung HL. Nitric oxide donors: biochemical pharmacology and therapeutics. Adv Pharmacol 1995;34:361-81
   PubMedGoogle Scholar
• Cavet ME, Vittitow JL, Impagnatiello F, et al. Nitric oxide (NO): an emerging target for the treatment of glaucoma. Invest Ophthalmol Vis Sci 2014;55:5005-15
   PubMed Web of Science ®Google Scholar
• Haefliger IO, Dettmann E, Liu R, et al. Potential role of nitric oxide and endothelin in the pathogenesis of glaucoma. Surv Ophthalmol 1999;43(Suppl1):S51-S8
   Web of Science ®Google Scholar
• Behar-Cohen FF, Goureau O, D’Hermies F, et al. Decreased intraocular pressure induced by nitric oxide donors is correlated to nitrite production in the rabbit eye. Invest Ophthalmol Vis Sci 1996;37:1711-15
   PubMed Web of Science ®Google Scholar
• Kotikoski H, Alajuuma P, Moilanen E, et al. Comparison of nitric oxide donors in lowering intraocular pressure in rabbits: role of cyclic GMP. J Ocul Pharmacol Ther 2002;18:11-23
   PubMed Web of Science ®Google Scholar
• Gerometta R, Alvarez LJ, Candia OA. Effect of sildenafil citrate on intraocular pressure and blood pressure in human volunteers. Exp Eye Res 2011;93:103-7
   PubMed Web of Science ®Google Scholar
• Gerometta R, Alvarez LJ, Candia OA. Effects of sildenafil and tadalafil on intraocular pressure in sheep: implications for aqueous humor dynamics. Invest Ophthalmol Vis Sci 2010;51:3139-44
   PubMed Web of Science ®Google Scholar
• Wirostko BM, Tressler C, Hwang LJ, et al. Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension. BMJ 2012;344:e554
   PubMed Web of Science ®Google Scholar
• Grunwald JE, Jacob SS, Siu K, et al. Acute effects of sldenafil ctrate (Viagra) on intraocular pressure in open-angle glaucoma. Am J Ophthalmol 2001;132:872-4
   PubMed Web of Science ®Google Scholar
• Nathanson JA. Nitrovasodilators as a new class of ocular hypotensive agents. J Pharmacol Exp Ther 1992;260:956-65
   PubMed Web of Science ®Google Scholar
• Borghi V, Bastia E, Guzzetta M, et al. A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma. J Ocul Pharmacol Ther 2010;26:125-32
   PubMed Web of Science ®Google Scholar
• Giuffrida S, Bucolo C, Drago F. Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma. J Ocul Pharmacol Ther 2003;19:527-34
   PubMed Web of Science ®Google Scholar
• Chiou SH, Chang CJ, Hsu WM, et al. Elevated nitric oxide level in aqueous humor of patients with acute angle-closure glaucoma. Ophthalmologica 2001;215:113-16
   PubMed Web of Science ®Google Scholar
• van Goor H, van den Born JC, Hillebrands JL, et al. Hydrogen sulfide in hypertension. Curr Opin Nephrol Hypertens 2016;25:107-13
   PubMed Web of Science ®Google Scholar
• Sowmya S, Swathi Y, Yeo AL, et al. Hydrogen sulfide: regulatory role on blood pressure in hyperhomocysteinemia. Vascul Pharmacol 2010;53:138-43
   PubMed Web of Science ®Google Scholar
• Sikora M, Pham K, Ufnal M. Hypotensive effect of S-adenosyl-L-methionine in hypertensive rats is reduced by autonomic ganglia and KATP channel blockers. Amino Acids 2016;48:1581-90
   PubMed Web of Science ®Google Scholar
• Ufnal M, Sikora M. The role of brain gaseous transmitters in the regulation of the circulatory system. Curr Pharm Biotechnol 2011;12:1322-33
   PubMed Web of Science ®Google Scholar
• Yang G, Wu L, Jiang B, et al. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008;322:587-90
   PubMed Web of Science ®Google Scholar
• Salvi A, Bankhele P, Jamil J, et al. Effect of hydrogen sulfide donors on intraocular pressure in rabbits. J Ocul Pharmacol Ther 2016;32:371-5
   PubMed Web of Science ®Google Scholar
• Njie-Mbye YF, Opere CA, Chitnis M, et al. Hydrogen sulfide: role in ion channel and transporter modulation in the eye. Front Physiol 2012;3:295
   PubMed Web of Science ®Google Scholar
• DeMarco VG, Aroor AR, Sowers JR. The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol 2014;10:364-76
   PubMed Web of Science ®Google Scholar
• Shiose Y. The aging effect on intraocular pressure in an apparently normal population. Arch Ophthalmol 1984;102:883-7
   PubMedGoogle Scholar
• Lee JS, Lee SH, Oum BS, et al. Relationship between intraocular pressure and systemic health parameters in a Korean population. Clin Exp Ophthalmol 2002;30:237-41
   PubMed Web of Science ®Google Scholar